FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2140987108> ?p ?o ?g. }

• W2140987108 abstract "Recent reductions in malaria in sub-Saharan Africa have been associated with increased coverage with long-lasting insecticidal nets (LLINs). Pyrethroids are currently the only insecticide class used for treating nets, and the rapid increase in resistance to pyrethroids in vector mosquitoes may jeopardise future vector control. Nets containing a novel combination of permethrin, a pyrethroid, and pyriproxyfen, an insect juvenile hormone mimic, (PPF-LLIN) may enhance malaria control, as well as reducing the spread of pyrethroid-resistant mosquitoes. This trial will determine whether PPF-LLINs provide incremental protection against malaria over current best practice of LLINs and prompt treatment in an area with pyrethroid-resistant vectors.A 2 armed cluster-randomised controlled trial will be conducted in Burkina Faso to assess whether PPF-LLIN (containing 2% permethrin and 1% pyriproxyfen w/w) provide better protection against clinical malaria in children than 2% permethrin-treated LLINs. Study subjects will be recruited and provided with LLINs at the start of the study. The LLINs will be exchanged for PPF-LLIN by cluster in a step-wedge fashion so 3 months before the end of the 2 year trial all participants will have a PPF-LLIN. The primary endpoint will be clinical malaria incidence measured by passive case detection in a cohort of children, aged 6 months to 5 years. Anaemia and parasite prevalence will also be measured in children during cross-sectional surveys. Exposure to malaria parasites will be assessed using light traps followed by identification of common vector species and their sporozoite infection rates. Safety evaluation will include recording of adverse events and pregnancy outcomes. The main endpoint analysis will include adjusting for distance between village clusters with different types of nets, as the impact of PPF-LLIN is likely to increase as larger areas are dominated by PPF-LLIN, reducing the spill over of mosquitoes from villages with LLINs.The step-wedge design is to measure the impact of an incrementally delivered environmental intervention where we expect the degree of control to be improved as more people use PPF-LLIN over a larger area. Trial findings will help inform policy makers on the effectiveness of PPF-LLIN nets for malaria control in areas of pyrethroid resistance.ISRCTN21853394 - AvecNet, registered on 3 April 2013." @default.
• W2140987108 created "2016-06-24" @default.
• W2140987108 creator A5009549474 @default.
• W2140987108 creator A5013139296 @default.
• W2140987108 creator A5043164969 @default.
• W2140987108 creator A5047233389 @default.
• W2140987108 creator A5047388405 @default.
• W2140987108 creator A5067983071 @default.
• W2140987108 creator A5071771296 @default.
• W2140987108 creator A5076225010 @default.
• W2140987108 date "2015-03-25" @default.
• W2140987108 modified "2023-10-15" @default.
• W2140987108 title "The AvecNet Trial to assess whether addition of pyriproxyfen, an insect juvenile hormone mimic, to long-lasting insecticidal mosquito nets provides additional protection against clinical malaria over current best practice in an area with pyrethroid-resistant vectors in rural Burkina Faso: study protocol for a randomised controlled trial" @default.
• W2140987108 cites W1831100553 @default.
• W2140987108 cites W1874330777 @default.
• W2140987108 cites W1913281388 @default.
• W2140987108 cites W1964149115 @default.
• W2140987108 cites W1966744959 @default.
• W2140987108 cites W1976821841 @default.
• W2140987108 cites W1977743896 @default.
• W2140987108 cites W2000048462 @default.
• W2140987108 cites W2015937705 @default.
• W2140987108 cites W2017766173 @default.
• W2140987108 cites W2020594804 @default.
• W2140987108 cites W2035457096 @default.
• W2140987108 cites W2038870495 @default.
• W2140987108 cites W2050410910 @default.
• W2140987108 cites W2053221118 @default.
• W2140987108 cites W2072974274 @default.
• W2140987108 cites W2083425921 @default.
• W2140987108 cites W2092798836 @default.
• W2140987108 cites W2094077008 @default.
• W2140987108 cites W2096309440 @default.
• W2140987108 cites W2101086336 @default.
• W2140987108 cites W2107077432 @default.
• W2140987108 cites W2108380884 @default.
• W2140987108 cites W2110676524 @default.
• W2140987108 cites W2112558871 @default.
• W2140987108 cites W2121626072 @default.
• W2140987108 cites W2126970879 @default.
• W2140987108 cites W2128489222 @default.
• W2140987108 cites W2140109370 @default.
• W2140987108 cites W2140874553 @default.
• W2140987108 cites W2146757755 @default.
• W2140987108 cites W2149136110 @default.
• W2140987108 cites W2153247789 @default.
• W2140987108 cites W2153429567 @default.
• W2140987108 cites W2154246179 @default.
• W2140987108 cites W2163644520 @default.
• W2140987108 cites W2164409574 @default.
• W2140987108 cites W2410358129 @default.
• W2140987108 cites W2442210167 @default.
• W2140987108 cites W2513676123 @default.
• W2140987108 cites W4254775864 @default.
• W2140987108 cites W70890866 @default.
• W2140987108 doi "https://doi.org/10.1186/s13063-015-0606-4" @default.
• W2140987108 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/4377002" @default.
• W2140987108 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/25873089" @default.
• W2140987108 hasPublicationYear "2015" @default.
• W2140987108 type Work @default.
• W2140987108 sameAs 2140987108 @default.
• W2140987108 citedByCount "19" @default.
• W2140987108 countsByYear W21409871082015 @default.
• W2140987108 countsByYear W21409871082016 @default.
• W2140987108 countsByYear W21409871082017 @default.
• W2140987108 countsByYear W21409871082018 @default.
• W2140987108 countsByYear W21409871082019 @default.
• W2140987108 countsByYear W21409871082021 @default.
• W2140987108 countsByYear W21409871082022 @default.
• W2140987108 crossrefType "journal-article" @default.
• W2140987108 hasAuthorship W2140987108A5009549474 @default.
• W2140987108 hasAuthorship W2140987108A5013139296 @default.
• W2140987108 hasAuthorship W2140987108A5043164969 @default.
• W2140987108 hasAuthorship W2140987108A5047233389 @default.
• W2140987108 hasAuthorship W2140987108A5047388405 @default.
• W2140987108 hasAuthorship W2140987108A5067983071 @default.
• W2140987108 hasAuthorship W2140987108A5071771296 @default.
• W2140987108 hasAuthorship W2140987108A5076225010 @default.
• W2140987108 hasBestOaLocation W21409871081 @default.
• W2140987108 hasConcept C104317684 @default.
• W2140987108 hasConcept C161176658 @default.
• W2140987108 hasConcept C18903297 @default.
• W2140987108 hasConcept C203014093 @default.
• W2140987108 hasConcept C2776035571 @default.
• W2140987108 hasConcept C2778048844 @default.
• W2140987108 hasConcept C2779752676 @default.
• W2140987108 hasConcept C2779985137 @default.
• W2140987108 hasConcept C2780348099 @default.
• W2140987108 hasConcept C33070731 @default.
• W2140987108 hasConcept C40767141 @default.
• W2140987108 hasConcept C55493867 @default.
• W2140987108 hasConcept C71924100 @default.
• W2140987108 hasConcept C86803240 @default.
• W2140987108 hasConcept C92087593 @default.
• W2140987108 hasConcept C99454951 @default.
• W2140987108 hasConceptScore W2140987108C104317684 @default.
• W2140987108 hasConceptScore W2140987108C161176658 @default.
• W2140987108 hasConceptScore W2140987108C18903297 @default.
• W2140987108 hasConceptScore W2140987108C203014093 @default.
• W2140987108 hasConceptScore W2140987108C2776035571 @default.

• next